Cardiovascular Clinical Trials In Beltsville, MD
Living with cardiovascular disease or at risk for a heart attack or stroke? You may qualify for this ASCVD clinical trial at Metropolitan Clinical Research.
Cardiovascular Disease Clinical Trials for Adults Living With ASCVD
Understanding ASCVD and the Need for Better Options
Atherosclerotic cardiovascular disease (ASCVD) can develop when plaque builds up inside the arteries, restricting blood flow and increasing the risk of heart attack, stroke, and other serious cardiovascular events. Even with lifestyle changes and available treatments, some people remain at risk, creating a need for additional treatment options.
Researchers are studying an investigational oral treatment to see whether it may help reduce the risk of major cardiovascular events in people with ASCVD or those at high cardiovascular risk.
Cardiovascular Disease Clinical Trials for Adults Living With ASCVD
Complete this form to see if you qualify for the study!
ASCVD Clinical Trial: Looking Toward Potential New Treatment Options
This clinical trial is evaluating an investigational treatment for cardiovascular disease to see whether it can lower the risk of adverse cardiovascular events in adults living with ASCVD or at high risk for their first event.
The findings may help researchers determine whether this investigational treatment could become a potential new option for reducing cardiovascular risk and protecting long-term heart health.
Why Participate at Metropolitan Clinical Research?
At Metropolitan Clinical Research, we take a patient-first approach to cardiovascular research. Our experienced research team is committed to conducting cardiovascular disease research studies with careful attention to participant safety, clear communication, and a supportive experience throughout every stage of the study.
- When you take part in this cardiovascular clinical trial in Beltsville, MD, you can expect:
- Experienced professionals conducting cardiovascular research
- Regular health assessments and study-related monitoring
- Clear guidance and communication throughout the study
- Your safety and well-being remain a priority
- A comfortable, supportive, and respectful study experience
Considering this ASCVD clinical trial? We’re here to answer your questions, explain what participation involves, and help you decide whether taking the next step is right for you.
Why Is This Study Needed?
ASCVD can develop as plaque builds up inside the arteries, increasing the risk of heart attack, stroke, and other serious cardiovascular events. Even when people are taking steps to manage their cardiovascular health, the risk of these events may remain. Researchers are continuing to look for potential new approaches that may help lower this risk.
By participating, you can help researchers evaluate a potential new treatment approach while contributing to research that may lead to better options for reducing cardiovascular risk in the future.
Eligibility Criteria
Take part in this ASCVD clinical trial and help researchers study an investigational treatment to prevent any major adverse CVD event.
- Age Group
18 years and older
- Gender
All
- Study Status
Recruiting
- Location
Beltsville, MD
Frequently Asked Questions
Answers to common questions about our clinical research.
What are cardiovascular disease clinical trials, and why are they important?
Cardiovascular research studies help researchers evaluate potential new treatments and better understand ways to prevent serious heart and blood vessel problems. Participation can contribute to knowledge that may improve future cardiovascular care.
How do I know if I may qualify for a cardiovascular clinical trial in Beltsville, MD?
You may be considered if you are an adult with established ASCVD or are at high risk for a first cardiovascular event. The study team will review your medical history and other eligibility requirements before enrollment.
What happens during an ASCVD clinical trial?
If you qualify and choose to participate, you will receive study-related care and attend scheduled visits for health assessments and monitoring. The research team will explain each step before you begin.
Does this study involve arterial occlusive diseases?
The study evaluates several serious vascular outcomes, including acute lower-limb ischemia and other events related to reduced blood flow through the arteries. The research team can explain how these outcomes relate to the study.
Is this a heart attack prevention study?
This study is not focused solely on heart attack prevention. It is part of major adverse cardiovascular events trials designed to evaluate whether the investigational treatment may reduce the risk of serious events, including cardiovascular death, heart attack, stroke, and other vascular complications.
Interested in Participating? We're Here to Help
Our team at Metropolitan Clinical Research is available to answer your questions and guide you through the next steps. Contact us today to learn more about our clinical research studies.